Baseimmune is pioneering the next generation of active immunotherapies by combining cutting-edge computational design with advanced protein engineering. Our platform creates bespoke antigens that address the complexity of chronic diseases, unlocking new possibilities where traditional approaches fall short. We are driven by the vision of transforming patient outcomes through bold, science-first innovation.
Board of Directors
Joshua
Blight
Hussein
Kanji
Phillip
Kemlo
Baseimmune
Hoxton Ventures
Baseimmune
Jamie Macfarlane
Kevin
Walton
Alex
Wilson
Creator Fund
Baseimmune
IQ Captial
Scientific Advisory Board
John
Cijiang He, MD
Scott L.
Friedman, MD
Toby
Maher, MD
Mount Sinai
Mount Sinai
USC
Paul
Noble, MD
Joel
Rurik, PhD
Formerly Cedars-Sinai
Formerly Karolinska Intitutet
baseimmune
®
© 2026 Baseimmune. All rights reserved
Apex, 1 Tribeca Walk, London, NW1 0QE
—
Designed and created with love by the Baseimmune Team ♥︎
